Collection of biological samples from brain tumor patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather biological samples, such as blood and cerebrospinal fluid, from patients diagnosed with brain tumors. The collected samples will be used for future research to better understand brain tumors and potentially improve treatment options. The study focuses on adult patients who can provide informed consent and are affiliated with a social security scheme. By building a comprehensive biobank, the study seeks to facilitate advancements in brain tumor research.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient whose diagnosis of brain tumor has been confirmed.
* Adult patients, from 18 years old and without upper age limit
* Patient affiliated to a social security scheme or equivalent.
* Patient able to consent, having dated and signed an informed consent

Exclusion Criteria:

* Pregnant or breastfeeding women
* Patient under guardianship or curators.
* Persons deprived of their liberty by a judicial or administrative decision

Where it's running

• Hospices Civils de Lyon
  Bron, Rhône, France Recruiting

Study contacts

• Study coordinator: François DUCRAY, Pr
• Email: francois.ducray@chu-lyon.fr
• Phone: 04 72 68 13 21

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions

  A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT07883720

• Maintenance radiotherapy after standard glioblastoma treatment

  This study tests whether a single 2 Gy maintenance radiotherapy dose after standard treatment is safe and feasible for adults with newly diagnosed glioblastoma.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT07831772

• BCB-276 CAR T therapy for DIPG in children and young adults

  This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.

  Recruiting at 3 sites Phase 2 BrainChild Bio, Inc · Los Angeles, California and 5 other locations · NCT07680439

• Temozolomide safety and effectiveness in adults with Grade III–IV glioma

  This study tests how safe and effective Amitzo temozolomide is in adults with Grade III or IV glioma in Iran, without a control group.

  Recruiting NanoAlvand · Tehran · NCT07675070

• Home-based vision training guided by brain imaging

  This study tests whether at‑home, image-guided visual training can improve visual field function for adults with stroke-related vision loss.

  Recruiting Georgetown University · Washington D.C., District of Columbia · NCT07635329

• Memantine and raloxifene to protect memory after brain radiation

  This study tests whether adding memantine and raloxifene to brain radiation can help adults preserve memory better than radiation alone.

  Recruiting Phase 2 The University of Texas Health Science Center at San Antonio · San Antonio, Texas · NCT07470606

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.